Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (151-160 of 621) with videos related to

Pageof 63
Sort By:
Rheumatology (Oxford, England)|December 1, 2021
Purinergic signalling in systemic sclerosisJakob Höppner, Cosimo Bruni, Oliver Distler, et al.
JMIR Formative Research|August 26, 2025
Multimodal Noninvasive Assessment of C-Reactive Protein for Systemic Inflammation in Adults: Cross-Sectional StudyJinjoo Shim, Sinziana Muraru, Vanessa Löw, et al.
Rheumatology (Oxford, England)|October 10, 2017
Muscle involvement in systemic sclerosis: points to consider in clinical trialsUlrich A Walker, Philip J Clements, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Jörg H W Distler, Britta Maurer, et al.
Annals of the Rheumatic Diseases|September 3, 2014
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosisPawel Zerr, Katrin Palumbo-Zerr, Jingang Huang, et al.
Rheumatology (Oxford, England)|February 2, 2024
Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosisFrancesca Tirelli, Elena Pachera, Sabrina Gmür, et al.
Experimental Dermatology|April 7, 2005
Nucleofection: a new, highly efficient transfection method for primary human keratinocytes*Jörg H W Distler, Astrid Jüngel, Mariola Kurowska-Stolarska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension StudyYannick Allanore, Oliver Distler, Alexandre Jagerschmidt, et al.
Arthritis Research & Therapy|March 20, 2019
Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional studyMichael Osthoff, Veronika K Jaeger, Ingmar A F M Heijnen, et al.
Respiratory Research|July 25, 2020
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating diseaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, et al.
Pageof 63

Showing results (151-160 of 621) with videos related to

Sort By:
Pageof 63
Rheumatology (Oxford, England)|December 1, 2021
Purinergic signalling in systemic sclerosisJakob Höppner, Cosimo Bruni, Oliver Distler, et al.
JMIR Formative Research|August 26, 2025
Multimodal Noninvasive Assessment of C-Reactive Protein for Systemic Inflammation in Adults: Cross-Sectional StudyJinjoo Shim, Sinziana Muraru, Vanessa Löw, et al.
Rheumatology (Oxford, England)|October 10, 2017
Muscle involvement in systemic sclerosis: points to consider in clinical trialsUlrich A Walker, Philip J Clements, Yannick Allanore, et al.
Annals of the Rheumatic Diseases|January 21, 2014
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) groupSuzana Jordan, Jörg H W Distler, Britta Maurer, et al.
Annals of the Rheumatic Diseases|September 3, 2014
Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosisPawel Zerr, Katrin Palumbo-Zerr, Jingang Huang, et al.
Rheumatology (Oxford, England)|February 2, 2024
Long non-coding RNA H19X as a regulator of mononuclear cell adhesion to the endothelium in systemic sclerosisFrancesca Tirelli, Elena Pachera, Sabrina Gmür, et al.
Experimental Dermatology|April 7, 2005
Nucleofection: a new, highly efficient transfection method for primary human keratinocytes*Jörg H W Distler, Astrid Jüngel, Mariola Kurowska-Stolarska, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2018
Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis: A Double-Blind, Randomized, Eight-Week Placebo-Controlled Study Followed by a Sixteen-Week Open-Label Extension StudyYannick Allanore, Oliver Distler, Alexandre Jagerschmidt, et al.
Arthritis Research & Therapy|March 20, 2019
Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional studyMichael Osthoff, Veronika K Jaeger, Ingmar A F M Heijnen, et al.
Respiratory Research|July 25, 2020
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating diseaseAnna-Maria Hoffmann-Vold, Yannick Allanore, Elisabeth Bendstrup, et al.
Pageof 63